Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
We report the first case of miltefosine rescue treatment carried out for visceral leishmaniasis (VL) relapse patient. Despite undergoing treatment regimens of liposomal amphotericin B (LAMB) 5 mg/kg (standard: 10 mg/kg) daily for 3 days during the first episode followed by LAMB 5 mg/kg stat and paro...
Saved in:
Main Authors: | Anup Bastola, Mitesh Shrestha, Bimal Sharma Chalise, Abhdesh Kumar Mishra, Lina Devkota |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2019/3634568 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relapse of Visceral Leishmaniasis in an HIV-Infected Patient Successfully Treated with a Combination of Miltefosine and Amphotericin B
by: Shauna McQuarrie, et al.
Published: (2015-01-01) -
Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis
by: Shyam Sundar, et al.
Published: (2015-01-01) -
Lingual Leishmaniasis Presenting to Maxillofacial Surgery in UK with Successful Treatment with Miltefosine
by: K. Kassam, et al.
Published: (2013-01-01) -
Chronic Visceral Leishmaniasis in a Nonendemic Region
by: Sudha Sharma, et al.
Published: (2024-12-01) -
Use of Oral Miltefosine for Cutaneous Leishmaniasis in Canadian Soldiers Returning from Afghanistan
by: Yoav Keynan, et al.
Published: (2008-01-01)